Log In
Print
BCIQ
Print
Print this Print this
 

PS278-05

  Manage Alerts
Collapse Summary General Information
Company Proteome Sciences plc
DescriptionCasein kinase 1 delta (CSNK1D; CKI-delta) inhibitor
Molecular Target Casein kinase 1 delta (CSNK1D) (CKI-delta)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today